Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

Chiu YL, Greene WC.

Annu Rev Immunol. 2008;26:317-53. doi: 10.1146/annurev.immunol.26.021607.090350. Review.

PMID:
18304004
[PubMed - indexed for MEDLINE]
2.

Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.

Wichroski MJ, Robb GB, Rana TM.

PLoS Pathog. 2006 May;2(5):e41. Epub 2006 May 12.

PMID:
16699599
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.

Izumi T, Shirakawa K, Takaori-Kondo A.

Mini Rev Med Chem. 2008 Mar;8(3):231-8. Review.

PMID:
18336343
[PubMed - indexed for MEDLINE]
4.

HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action.

Santa-Marta M, Aires da Silva F, Fonseca AM, Rato S, Goncalves J.

Mol Immunol. 2007 Jan;44(4):583-90. Epub 2006 Mar 31.

PMID:
16580072
[PubMed - indexed for MEDLINE]
5.

Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.

Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T.

Virology. 2006 Jan 20;344(2):263-6. Epub 2005 Nov 21.

PMID:
16303161
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Multifaceted antiviral actions of APOBEC3 cytidine deaminases.

Chiu YL, Greene WC.

Trends Immunol. 2006 Jun;27(6):291-7. Epub 2006 May 4. Review.

PMID:
16678488
[PubMed - indexed for MEDLINE]
8.

HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G.

Kremer M, Schnierle BS.

Curr HIV Res. 2005 Oct;3(4):339-44. Review.

PMID:
16250885
[PubMed - indexed for MEDLINE]
9.

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O.

Nature. 2005 Jan 27;433(7024):430-3.

PMID:
15674295
[PubMed - indexed for MEDLINE]
10.

APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.

Franca R, Spadari S, Maga G.

Med Sci Monit. 2006 May;12(5):RA92-8. Review.

PMID:
16641889
[PubMed - indexed for MEDLINE]
11.

The viral infectivity factor (Vif) of HIV-1 unveiled.

Rose KM, Marin M, Kozak SL, Kabat D.

Trends Mol Med. 2004 Jun;10(6):291-7. Review.

PMID:
15177194
[PubMed - indexed for MEDLINE]
12.

APOBEC-mediated viral restriction: not simply editing?

Holmes RK, Malim MH, Bishop KN.

Trends Biochem Sci. 2007 Mar;32(3):118-28. Epub 2007 Feb 15. Review.

PMID:
17303427
[PubMed - indexed for MEDLINE]
13.

APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.

Chiu YL, Greene WC.

J Biol Chem. 2006 Mar 31;281(13):8309-12. Epub 2005 Dec 30. Review.

PMID:
16407183
[PubMed - indexed for MEDLINE]
Free Article
14.

Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements.

Esnault C, Priet S, Ribet D, Heidmann O, Heidmann T.

Retrovirology. 2008 Aug 14;5:75. doi: 10.1186/1742-4690-5-75.

PMID:
18702815
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.

PLoS One. 2008;3(12):e3963. doi: 10.1371/journal.pone.0003963. Epub 2008 Dec 17.

PMID:
19088851
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Russell RA, Pathak VK.

J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.

PMID:
17522216
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA.

Yang B, Chen K, Zhang C, Huang S, Zhang H.

J Biol Chem. 2007 Apr 20;282(16):11667-75. Epub 2007 Feb 1.

PMID:
17272283
[PubMed - indexed for MEDLINE]
Free Article
18.

Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.

Huthoff H, Towers GJ.

Trends Microbiol. 2008 Dec;16(12):612-9. doi: 10.1016/j.tim.2008.08.013. Epub 2008 Oct 29. Review.

PMID:
18976920
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM.

J Exp Med. 2006 Jan 23;203(1):41-6. Epub 2006 Jan 17. Erratum in: J Exp Med. 2006 Dec 25;203(13):2963.

PMID:
16418394
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Intracellular restriction factors in mammalian cells--An ancient defense system finds a modern foe.

Baumann JG.

Curr HIV Res. 2006 Apr;4(2):141-68. Review.

PMID:
16611054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk